Tandem Diabetes Care
11045 Roselle Street
Suite 200
San Diego
California
92121
United States
Tel: 858-366-6900
Fax: 858-362-7070
Website: http://www.tandemdiabetes.com/
240 articles about Tandem Diabetes Care
-
Tandem Diabetes Care Prices Upsized Private Placement of $275.0 Million of Convertible Senior Notes Due 2029
3/6/2024
Tandem Diabetes Care, Inc. announced the pricing of $275.0 million aggregate principal amount of 1.50% Convertible Senior Notes due 2029 in a private placement to persons reasonably believed to be qualified institutional buyers pursuant to Rule 144A under the Securities Act of 1933, as amended.
-
Tandem Diabetes Care Announces Proposed Private Placement of Convertible Notes - March 04, 2024
3/4/2024
Tandem Diabetes Care, Inc., a global insulin delivery and diabetes technology company, announced that it intends to offer, subject to market conditions and other factors, $250.0 million aggregate principal amount of its Convertible Senior Notes due 2029 in a private placement to persons reasonably believed to be qualified institutional buyers pursuant to Rule 144A under the Securities Act of 1933, as amended.
-
Tandem Diabetes Care Announces Fourth Quarter and Full Year 2023 Financial Results and 2024 Financial Guidance
2/21/2024
Tandem Diabetes Care, Inc. (NASDAQ: TNDM), a global insulin delivery and diabetes technology company, today reported its financial results for the quarter and year ended December 31, 2023 and provided its financial guidance for the year ending December 31, 2024.
-
Tandem Diabetes Care Launches Tandem Mobi, the World’s Smallest, Durable Automated Insulin Delivery System
2/13/2024
Tandem Diabetes Care, Inc. announced the United States commercial launch of its new Tandem Mobi, the world’s smallest, durable automated insulin delivery system for people living with diabetes.* The company has begun taking orders and shipping to eligible customers in the United States.
-
Tandem Diabetes Care Announces Upcoming Conference Presentations - February 08, 2024
2/8/2024
Tandem Diabetes Care, Inc., a leading insulin delivery and diabetes technology company, announced that management will present a company update at the following investor conferences.
-
Tandem Diabetes Care to Announce Fourth Quarter and Full Year 2023 Financial Results on February 21, 2024
1/22/2024
Tandem Diabetes Care, Inc. (NASDAQ: TNDM), a leading insulin delivery and diabetes technology company, plans to release its fourth quarter and full year 2023 results after the financial markets close on Wednesday, February 21, 2024.
-
Tandem Diabetes Care Announces Full U.S. Launch of Tandem Source, a New Diabetes Management Platform for Customers and Healthcare Providers
12/12/2023
Tandem Diabetes Care, Inc., a leading insulin delivery and diabetes technology company, announced the launch of Tandem Source, a diabetes management platform for insulin pump users and healthcare providers.
-
Tandem Diabetes Care Launches t:slim X2 Insulin Pump Software with Dexcom G7 CGM Integration in U.S.
12/6/2023
Tandem Diabetes Care, Inc. today announced the launch of updated t:slim X2™ insulin pump software with Dexcom G7 Continuous Glucose Monitoring (CGM) integration in the United States.
-
Tandem Diabetes Care Announces Upcoming November 2023 Conference Presentations
11/6/2023
Tandem Diabetes Care, Inc., a leading insulin delivery and diabetes technology company, announced that management will present a company update at the following investor conferences.
-
Tandem Diabetes Care Appoints Mark Novara as EVP and Chief Commercial Officer
11/1/2023
Tandem Diabetes Care, Inc., a leading insulin delivery and diabetes technology company, announced the appointment of Mark Novara as Executive Vice President and Chief Commercial Officer, effective November 13, 2023.
-
Tandem Diabetes Care Announces Third Quarter 2023 Financial Results
11/1/2023
Tandem Diabetes Care, Inc., a global insulin delivery and diabetes technology company, reported its financial results for the quarter ended September 30, 2023 and updated its financial guidance for the year ending December 31, 2023.
-
Tandem Diabetes Care to Announce Third Quarter 2023 Financial Results on November 1, 2023
10/10/2023
Tandem Diabetes Care, Inc. (NASDAQ: TNDM), a leading insulin delivery and diabetes technology company, plans to release its third quarter 2023 results after the financial markets close on Wednesday, November 1, 2023.
-
Tandem Diabetes Care Announces Upcoming September 2023 Conference Presentations
8/24/2023
Tandem Diabetes Care, Inc., a leading insulin delivery and diabetes technology company, announced that management will present a company update at the following investor conferences.
-
Tandem Diabetes Care Announces Technology Access Program to Provide Customers with Purchase Pathway to the Tandem Mobi System
8/3/2023
Tandem Diabetes Care, Inc., a leading insulin delivery and diabetes technology company, announced a limited time offer for its Tandem Choice technology access program.
-
Tandem Diabetes Care Announces Second Quarter 2023 Financial Results and Updated Full Year 2023 Financial Guidance
8/3/2023
Tandem Diabetes Care, Inc. (NASDAQ: TNDM), a global insulin delivery and diabetes technology company, today reported its financial results for the quarter ended June 30, 2023 and updated its financial guidance for the year ending December 31, 2023.
-
Tandem Diabetes Care to Present at the UBS MedTech, Tools and Genomics Summit 2023
8/1/2023
Tandem Diabetes Care, Inc., a leading insulin delivery and diabetes technology company, announced that management will present a company update at the UBS MedTech, Tools and Genomics Summit 2023 on Wednesday, August 16, 2023 at 2:00pm Eastern Time.
-
Tandem Diabetes Care to Announce Second Quarter 2023 Financial Results on August 3, 2023
7/10/2023
Tandem Diabetes Care, Inc., a leading insulin delivery and diabetes technology company, plans to release its second quarter 2023 results after the financial markets close on Thursday, August 3, 2023.
-
Tandem Diabetes Care to Present at the 2023 Jefferies Healthcare Conference
5/24/2023
Tandem Diabetes Care, Inc., a leading insulin delivery and diabetes technology company, announced that management will present a company update at the Jefferies Healthcare Conference on Thursday, June 8, 2023 at 1:30pm Eastern Time.
-
Tandem Diabetes Care Announces First Quarter 2023 Financial Results and Reaffirms Full Year 2023 Financial Guidance
5/3/2023
Tandem Diabetes Care, Inc. (NASDAQ: TNDM), a global insulin delivery and diabetes technology company, today reported its financial results for the quarter ended March 31, 2023 and reaffirmed its financial guidance for the year ending December 31, 2023.
-
Tandem Diabetes Care to Present at the BofA Securities 2023 Health Care Conference
4/20/2023
Tandem Diabetes Care, Inc., a leading insulin delivery and diabetes technology company, announced that management will present a company update at the BofA Securities 2023 Health Care Conference on Wednesday, May 10, 2023 at 4:40pm Eastern Time.